Pantoprazol Sun Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pantoprazol Sun Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and erosion healing. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Pantoprazol Sun Pharma may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme elevation: signs of hepatic stress.

When prescribing Pantoprazol Sun Pharma, clinicians should consider several safety aspects. - Assess renal function: adjust if severe impairment is present. - Evaluate hepatic function: use with caution in moderate to severe liver disease. - Review concomitant medications: potential for altered drug absorption. - Limit duration of use: avoid unnecessary long‑term therapy. - Monitor electrolytes: especially magnesium during prolonged treatment. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Sun Pharma can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption leading to therapeutic failure. - Atorvastatin and other CYP3A4 substrates: increased plasma concentrations.

Moderate Interactions (Monitor Closely): - Clopidogrel: diminished antiplatelet effect. - Warfarin: potential alteration of INR values. - Methotrexate: increased systemic exposure, especially at high doses. - Digoxin: modest increase in serum levels. - Iron supplements: decreased iron absorption when taken simultaneously.